Orchid Pharma Ltd Quarterly Results

Gross Sales

172.93

237.48

217.34

222.7

244.41

Excise Duty

0

0

0

0

0

Net Sales

172.93

237.48

217.34

222.7

244.41

Other Operating Income

0

0

0

0

0

Other Income

11.45

3.9

8.49

7.52

7.57

Total Income

184.38

241.38

225.83

230.22

251.98

Total Expenditure

158.75

209.5

190.98

192.36

211.91

PBIDT

25.62

31.88

34.85

37.85

40.06

Interest

3.26

3.92

3.8

3.33

3.5

PBDT

22.37

27.97

31.06

34.53

36.56

Depreciation

8.65

8.87

8.61

8.63

8.44

Minority Interest Before NP

0

0

0

0

0

Tax

0

0.06

0

0

-0.15

Deferred Tax

0

-0.1

0

0

0

Reported Profit After Tax

13.71

19.13

22.45

25.9

28.27

Minority Interest After NP

0

0

0

0

0

Net Profit after Minority Interest

14.91

22.29

20.78

27.24

29.35

Extra-ordinary Items

0

0

0

0

0

Adjusted Profit After Extra-ordinary item

14.91

22.29

20.78

27.24

29.35

EPS (Unit Curr.)

2.94

4.4

4.1

5.37

5.79

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

50.72

50.72

50.72

50.72

50.72

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

14.81

13.42

16.03

16.99

16.39

PBDTM(%)

12.93

11.77

14.29

15.5

14.95

PATM(%)

7.92

8.05

10.32

11.62

11.56